NPI 1841429156: Open Payments
NPI 1841429156. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,960 in 38 payments from 9 companies in 2025. Trend: 2023 $70,362 · 2024 $54,209 · 2025 $4,960
Consulting: $3,350Food & beverage: $1,610
| Company | Payments | Amount |
|---|---|---|
| MML US, Inc. | 19 | $3,824 |
| Boston Scientific Corporation | 9 | $569 |
| Spinal Simplicity, LLC | 2 | $259 |
| BIOTRONIK NRO, Inc. | 1 | $109 |
| Globus Medical, Inc. | 1 | $59 |
| Stryker Corporation | 2 | $49 |
| ABBVIE INC. | 2 | $39 |
| Abbott Laboratories | 1 | $29 |
| IBSA Pharma Inc. | 1 | $23 |
Products named: ReActiv8, Intracept, HA MINUTEMAN G3-R, Intracept RF Probe, Prospera, Vyrsa V1, QULIPTA, ETERNA.
